Initially the market thought Biogen's Alzheimers trial results were good but after the readout of the data there seems to be more questions...
This could impact ACW SP possitively.
DYOR
https://uk.finance.yahoo.com/news/biogen-eisai-sink-much-awaited-150700734.html?.tsrc=applewf
renewed interest, page-25
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $103.0M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $96.33K | 2.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1514540 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 168542 | 3 |
View Market Depth
| Last trade - 13.19pm 10/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |